Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein Nanoparticle Vaccine With Matrix-M Adjuvant in Healthy Adults.
Fries L, Cho I, Krähling V, Fehling SK, Strecker T, Becker S, Hooper JW, Kwilas SA, Agrawal S, Wen J, Lewis M, Fix A, Thomas N, Flyer D, Smith G, Glenn G.
Fries L, et al.
J Infect Dis. 2020 Jul 23;222(4):572-582. doi: 10.1093/infdis/jiz518.
J Infect Dis. 2020.
PMID: 31603201
Clinical Trial.